NBC Securities’s Inhibrx INBX Stock Holding History

NBC Securities’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$370K	Buy	3,900 +100	+3%	+$10K	0.03%	642
2026 Q1	$255K	Buy	3,800 +800	+27%	+$59.3K	0.02%	760
2025 Q4	$237K	Hold	3,000	–	–	0.02%	781
2025 Q3	$101K	Buy	+3,000	New	+$73.9K	0.01%	1068

Other funds holding INBX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NBC Securities's INBX Position: Q2 2026 in Review

NBC Securities increased its Inhibrx (INBX) stake by 2.6% in Q2 2026, buying an estimated $10K and bringing the position to 3,900 shares worth $370K. The position accounts for 0.03% of the portfolio, ranked #642.

NBC Securities first reported a position in INBX in Q3 2025 and has held it in 4 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

NBC Securities held 3,900 shares of Inhibrx worth $370K as of Q2 2026.
NBC Securities bought 100 Inhibrx shares in Q2 2026, an estimated $10K.
Inhibrx made up 0.03% of NBC Securities's portfolio in Q2 2026, its #642 holding.
NBC Securities first reported a position in Inhibrx in Q3 2025 and has held it in 4 quarters since.
163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.